Agilon Net Income From Continuing Ops from 2010 to 2024

AGL Stock  USD 2.23  0.10  4.69%   
Agilon Health Net Loss yearly trend continues to be quite stable with very little volatility. The value of Net Loss is projected to decrease to about -93.3 M. From the period between 2010 and 2024, Agilon Health, Net Loss regression line of its data series had sample variance of 6155.5 T and sample variance of 6155.5 T. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-88.8 M
Current Value
-93.3 M
Quarterly Volatility
78.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 936.1 K, Interest Income of 5.6 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 8.14. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
  
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Latest Agilon Health's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of agilon health over the last few years. It is Agilon Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agilon Health's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Pretty Stable
   Net Income From Continuing Ops   
       Timeline  

Agilon Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(126,845,243)
Coefficient Of Variation(61.85)
Mean Deviation37,151,834
Median(114,455,000)
Standard Deviation78,457,102
Sample Variance6155.5T
Range342.3M
R-Value(0.14)
Mean Square Error6504.7T
R-Squared0.02
Significance0.63
Slope(2,402,681)
Total Sum of Squares86177.2T

Agilon Net Income From Continuing Ops History

2024-93.3 M
2023-88.8 M
2022-107.3 M
2021-405.5 M
2020-63.2 M

About Agilon Health Financial Statements

Agilon Health investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-88.8 M-93.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:
Check out the analysis of Agilon Health Correlation against competitors.
For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
11.951
Earnings Share
(0.76)
Revenue Per Share
13.717
Quarterly Revenue Growth
0.276
Return On Assets
(0.1)
The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.